Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Body mass index influence interferon-beta treatment response in multiple sclerosis.
Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease.
The need for a disease-specific prospective pregnancy registry for multiple sclerosis (MS).
Advances in biomarker research in multiple sclerosis.
Chronic inflammatory demyelinating polyneuropathy associated with alopecia totalis and Sjögren syndrome.
Interactions between Neutrophils, Th17 Cells, and Chemokines during the Initiation of Experimental Model of Multiple Sclerosis.
Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis.
Resveratrol Exacerbates Both Autoimmune and Viral Models of Multiple Sclerosis.
"Her illness is a project we can work on together": developing a collaborative family-centered intervention model for newly diagnosed multiple sclerosis.
Effects of High Glucose on Cell Viability and Differentiation in Primary Cultured Schwann Cells: Potential Role of ERK Signaling Pathway.
Intrathecal lipid-specific oligoclonal IgM synthesis associates with retinal axonal loss in multiple sclerosis.
CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
Human myelin proteome and comparative analysis with mouse myelin.
Pediatric idiopathic transverse myelitis presenting as an anterior cord syndrome: A case report.
Immunomodulation by vitamin D in multiple sclerosis: More than IL-17.
Lung inflammation stalls Th17 cell migration en route to the central nervous system during the development of experimental autoimmune encephalomyelitis.
Vitamin D in the healthy and inflamed central nervous system: access and function.
A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
Deficiency of NF-kappaB c-Rel Accelerates the Development of Autoimmune Diabetes in Non-Obese Diabetic Mice.
[Pathology, diagnosis, and treatment of combined central and peripheral demyelination].
Seroprevalence of NMO-IgG among patients with neuromyelitis optica and opticospinal multiple sclerosis.
Disease activity return after natalizumab cessation in multiple sclerosis.
Daily fingolimod administration may cause lymphopenia but alternate-day administration may be too little to inhibit disease activity.
High immunogenicity of intracellular myelin oligodendrocyte glycoprotein epitopes.
What you cannot get from routine MRI of MS patient and why - The growing need for atrophy assessment and seeing beyond the plaque.

Pages